HOME >> MEDICINE >> NEWS
Emory conference to educate health professionals about 'metabolic syndrome'

An estimated 25 percent of adults over the age of 20 and close to 50 percent of adults over the age of 50 have the component risk factors that make up Metabolic Syndrome. The emerging health problem is the focus of a symposium for health professionals on Friday, May 21, hosted by the Emory University School of Medicine.

Thirteen nationally recognized experts on this increasingly common disorder will present at a daylong conference called "Metabolic Syndrome: An Obesity-Related National Epidemic---Mechanisms, Clinical Care and Future Directions. The event is CME-accredited and will include session topics on the clinical characteristics, pathogenesis and treatment of the metabolic syndrome, its associated conditions, and future research directions. It will be held from 8:00 a.m. to 5:15 p.m. in the auditorium of the Woodruff Health Sciences Center Administration Building on the Emory campus at 1440 Clifton Road.

Metabolic Syndrome, also known as Syndrome X, is a clustering of cardiovascular disease risk factors that is highly linked to obesity. It causes an increased risk of coronary heart disease, type 2 diabetes, and other diseases related to plaque buildups in artery walls, such as stroke and peripheral vascular disease. The diagnosis of the condition is based on the presence of three or more cardiovascular disease risk factors, including increased abdominal fat, pre-diabetes, high blood pressure, evidence of mild generalized inflammation, low blood levels of "good" cholesterol (HDL cholesterol) and/or high blood levels of triglycerides (circulating fats in the blood).

"The actual criteria for diagnosis of Metabolic Syndrome are still being debated by researchers," says Thomas R. Ziegler, M.D., associate professor of medicine, Department of Medicine, and director of the Emory Center for Clinical and Molecular Nutrition. "For example, some criteria include abnormalities such as a tendency for easy blood clotting and evidence of oxidative
'"/>

Contact: Tia Webster
twebste@emory.edu
404-727-5692
Emory University Health Sciences Center
13-May-2004


Page: 1 2 3

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
5. Emory researchers find race and gender gaps in treatment of heart attack
6. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
7. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
8. Emory scientists find marker for long-term immunity
9. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
10. Emory scientists link atrial fibrillation with decrease in nitrous oxide
11. Immune memory from smallpox vaccination lasts more 50 years, according to Emory research

Post Your Comments:
(Date:3/6/2015)... Toronto, ON (PRWEB) March 06, 2015 ... with the Canadian Celiac Association, is pleased to ... founded by Dufflet Rosenberg, has expanded their product ... and they are as scrumptious and as satisfying ... is hand-crafted from scratch, and never contains hydrogenated ...
(Date:3/6/2015)... FL (PRWEB) March 06, 2015 The producers ... March 2015 air dates for Spokane, Washington and vicinity. This ... places to shop and dine, and many outdoor activities. It ... supporting the local economy. Six major hospitals call the city ... the Canadian border. The medically-focused cable TV program will be ...
(Date:3/6/2015)... March 06, 2015 As the Mayo ... be discussed, Ford & Associates Nationwide Legal Services, A.P.C., ... 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., Case ... California. , “In light of a recently filed ... Benicar to evaluate and explore the Mayo Clinic's Benicar ...
(Date:3/5/2015)... PCR (dPCR) and qPCR market is expected to reach $3.97 billion ... The global digital PCR (dPCR) and qPCR market is estimated to ... the mature markets such as the U.S., Germany, France and U.K.) ... the Asia-Pacific region is expected to grow at the highest CAGR ... PCR (dPCR) and qPCR market is driven by factors such as ...
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a leading ... market, reported record revenue of $4.79 million for the ... million in the year-ago fourth quarter demonstrating the Company’s ... strong fourth quarter revenue growth reflects the market’s growing ... driving increased surgeon adoption of our unique product portfolio ...
Breaking Medicine News(10 mins):Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4
(Date:3/5/2015)... SAN DIEGO , March 5, 2015 /PRNewswire/ ... company engaged in the development of biosimilar therapeutics ... announced today that its fourth quarter and full ... Monday, March 16, 2015, before the market opens ... management will host a conference call to discuss ...
(Date:3/5/2015)... MOUNTAIN VIEW, Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... fourth quarter and year ended January 3, 2015.  ... 2014, a record for the Company and up 11% from ... were $42.8 million, also a record, up 12% from $38.3 ... fourth quarter was 50.1%, up from 48.6% in the fourth ...
(Date:3/5/2015)... , March 5, 2015  As the pharmaceutical ... regulations, Ethics & Compliance professionals are placing a ... new survey issued today by LRN, the leader ... An overwhelming majority of respondents expressed that clarity ... important component of E&C training programs (57%), trumping ...
Breaking Medicine Technology:Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3
Cached News: